arrow
Back
M

Matthew D. Galsky

icahn school of medicine at mount sinai

79H-index
851Paper Count
3.4WCitation Count
Published Papers 253
Publication Date
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma
err2026-05-16
err0
PREAI
errMatthew D. Galsky; Alexandra Drakaki; Arnab Basu; Bradley McGregor; Jens Bedke; Yohann Loriot; Eiji Kikuchi; Jun Guo; Benjamin Garmezy; Srikala S. Sridhar; Parminder Singh; Vadim S. Koshkin; Mark Fleming; Gunnar Klauss; Daisy Lin; Chelsea Liu; Andrea B. Apolo; Thomas Powles
errShare
errSave
How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study
err2026-04-01
err0
PREAI
errGupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S.; Bedke, Jens; Valderrama, Begona P.; Kikuchi, Eiji; Flechon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D.; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S.; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L.; Purnajo, Intan; McManus, Shauna; Powles, Thomas
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment
errMed
IF11.8
err2025-10-30
err0
errOAAI
errSujit S. Nair; Dimple Chakravarty; Sreekumar Balan; Alexander Hakansson; Manuel Duval; Elai Davicioni; Yang Liu; Swati Bhardwaj; Tin Htwe Thin; Monica Garcia-Barros; Kenneth Haines; Majd Al Shaarani; Rachel Weil; Marcia Meseck; Parita Ratnani; Monali Fatterpekar; Elena Gonzalez-Gugel; Adam Farkas; Vinayak Wagaskar; Ivan Jambor; Kacie Schlussel; Cristina Pasat-karasik; Kamala Bhatt; Zachary Dovey; Adriana Pedraza; Akriti Gupta; Dara Lundon; Ante Peros; Sneha Parekh; Lily Davenport; Xiangfu Zhang; Raghav Gupta; Macy Robison; Cynthia Knauer; Ethan Ellis; Dmitry Rykunov; Boris Reva; Babu Padanilam; Matthew D. Galsky; Rachel Brody; Mani Menon; Andres M. Salazar; Nina Bhardwaj; Ashutosh K. Tewari
errShare
errSave
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
err2025-10-17
err0
errOAAI
errM.D. Galsky; J.E. Gschwend; M.I. Milowsky; M. Schenker; B.P. Valderrama; Y. Tomita; A. Bamias; T. Lebret; S.F. Shariat; S.H. Park; M. Agerbaek; G. Jha; F. Stenner; D. Ye; F. Giudici; J. Connors; S. Gupta; A. Chhibber; J. Zhang; D.F. Bajorin; J.A. Witjes
errShare
errSave
Clinical utility of tumour-informed circulating tumour DNA in patients with testicular cancer
err2025-10-07
err0
PREAI
errReuben Ben-David; Ahmed Eraky; Brenda Hug; Matthew D. Galsky; Che-Kai Tsao; Kyrollis Attalla; Peter Wiklund; Reza Mehrazin; John P. Sfakianos
errShare
errSave
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials
errCancer
IF5.1
err2025-09-26
err0
PREAI
errAlexander B. Karol MD; Rodrigo Paredes MD; Anna Argulian BS; Himanshu Joshi MBBS, PhD; Lexi Weintraub BS; Kasopefoluwa Oguntuyo MD, PhD; Justin Miller BS; Yu Fujiwara MD; Deborah B. Doroshow MD, PhD; Matthew D. Galsky MD
errShare
errSave
HER2 and urothelial carcinoma: current understanding and future directions
err2025-08-15
err0
PREAI
errDaniele Raggi; Emanuele Crupi; Filippo Pederzoli; Alberto Martini; Alberto Briganti; Omar Alhalabi; Peter H. O’Donnell; Jeffrey Ross; Shilpa Gupta; Ashish M. Kamat; Bishoy M. Faltas; Peter C. Black; Phillip E. Spiess; Petros Grivas; Jianjun Gao; Andrea B. Apolo; Robert A. Huddart; Andrea Necchi; Matthew D. Galsky
errShare
errSave
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
err2025-08-07
err0
PREAI
errMatthew D. Galsky; Dean F. Bajorin; Yoshihiko Tomita; Dingwei Ye; Mads Agerbaek; Deborah Enting; Avivit Peer; Matthew Milowsky; Ko Kobayashi; Marc-Oliver Grimm; Frank Stenner; Justin M. David; Jun Li; Scott D. Chasalow; Federico Nasroulah; Abraham Apfel; Keziban Ünsal-Kaçmaz; Andrea Necchi
errShare
errSave
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
err2025-08-06
err0
PREAI
errSusan Halabi; Siyuan Guo; Bin Luo; Chenxi Yu; Todd P. Knutson; Anna Kobilka; Jacqueline Lyman; Himisha Beltran; Emmanuel S. Antonarakis; Matthew D. Galsky; Jonathan E. Rosenberg; Charles J. Ryan; Eric J. Small; W.Kevin Kelly; Michael J. Morris; David Page; Scott M. Dehm; Andrew J. Armstrong
errShare
errSave
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma
err2025-07-29
err0
errOAAI
errThomas B. Powles; Enrique Grande; Nimira Alimohamed; Niara Oliveira; Srikala S. Sridhar; Alexandra Drakaki; Ravindran Kanesvaran; Yohann Loriot; Andrea Necchi; Sonia Franco; Dingfeng Jiang; Kristel Apolinario; Wei Zhang; Matthew D. Galsky
errShare
errSave
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
err2025-07-21
err0
errOAAI
errNeal D. Shore; Thomas B. Powles; Jens Bedke; Matthew D. Galsky; Joan Palou Redorta; Ja Hyeon Ku; Michal Kretkowski; Evanguelos Xylinas; Boris Alekseev; Dingwei Ye; Félix Guerrero-Ramos; Alberto Briganti; Girish S. Kulkarni; Julia Brinkmann; Anna-Maria Calella; Rossano Cesari; Anthony Eccleston; Elisabete Michelon; Jennifer Vermette; Caimiao Wei; Gary D. Steinberg
errShare
errSave
errShare
errSave
The role of HER2-targeted therapy in urothelial carcinomas
err2025-06-12
err0
PREAI
errJeanny B. Aragon-Ching; Matthew D. Galsky
errShare
errSave
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
errShare
errSave
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial
err2025-05-20
err0
errOAAI
errMatthew D. Galsky; Michiel S. van der Heijden; Thomas Powles; Melanie Claps; Mauricio Burotto; Michael Schenker; Juan Pablo Sade; Aristotelis Bamias; Philippe Beuzeboc; Jens Bedke; Jan Oldenburg; Yüksel Ürün; Dingwei Ye; Begoña P. Valderrama; Yoshihiko Tomita; Ruiyun Jiang; Jeiry Filian; Lily Wang; Maximiliano van Kooten Losio; Guru Sonpavde
errShare
errSave
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
err2024-08-01
err5
PREAI
errGrivas, Petros; Koshkin, Vadim S.; Chu, Xiangying; Cole, Suzanne; Jain, Rohit K.; Dreicer, Robert; Cetnar, Jeremy P.; Sundi, Debasish; Gartrell, Benjamin A.; Galsky, Matthew D.; Woo, Brianna; Li-Ning-Tapia, Elsa; Hahn, Noah M.; Carducci, Michael A.
errShare
errSave